QuVa Pharma will continue to leverage the healthcare investment experience and deep resources of Bain Capital Private Equity to actively expand its current operations and open additional locations. “This large facility is a key component of the QuVa expansion strategy,” said Chris Gordon, a Managing Director of Bain Capital Private Equity. “We are pleased to support the QuVa Pharma management team as they continue to acquire, build and operate quality-focused compounding facilities. We are encouraged by the strong market demand for their innovative, safety-oriented approach and will continue to commit significant resources in backing this industry-pioneering venture.”
The Hardware and Equipment Business Unit’s mission is to provide the best instrumentation and equipment that meets our customer’s User Requirements and to provide the necessary support and service to ensure worry-free operation over the instruments and equipment life time. The Hardware and Equipment Business Unit includes a Metrology division that has an ISO 9001:2008 certified calibration laboratory. The Metrology group can calibrate Climet™ particle counters, GE Kaye™ 2000 Validators™, Shortridge™ Hoods, pressure and temperature measuring instruments. PSC Biotech has all equipment calibrated to NIST traceable standards, and our all of our equipment is qualified per internal PSC protocols. PSC Biotech has a validated, calibration database for managing GxP instruments.
Oncologists, and especially Pediatric Oncologists, have been clear that there is a tremendous unmet need here and we believe Annamycin has the potential to fill that need and change forever how children with leukemia are treated. The severity of this unmet need may allow us to position Annamycin for accelerated approval under FDA guidelines and we will be working hard this year to secure an accelerated approval pathway. We look forward to moving quickly to translate this important breakthrough into new hope for those children who have run out of options.